ARCHIVES

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

November 5, 1993

House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs

April 26, 1996

Colorectal Screening Rates Lower In Safety Net System

September 25, 2009

In Brief: Hospices Urges To Develop Program For AIDs Victims; Companies Give $25,5000 To NCI Fund

November 1, 1985

UT Health Science Center dedicates new Children’s Cancer Research Institute.

March 12, 2004

Research Triangles Lands Plant Drug Contract Renewal

April 9, 1976